TY - JOUR
T1 - Asthma Over the Age of 65
T2 - All's Well That Ends Well
AU - Baptist, Alan P.
AU - Busse, Paula J.
N1 - Funding Information:
Conflicts of interest: A. P. Baptist is employed by the University of Michigan, Division of Allergy; and has received research grants from Shire (on the topic of Angioedema), Novartis (on the topic of Asthma), and the National Institutes of Health (grant no. 1 R01 AG043401-01). P. J. Busse is employed by Mount Sinai School of Medicine.
Publisher Copyright:
© 2018 American Academy of Allergy, Asthma & Immunology
PY - 2018/5/1
Y1 - 2018/5/1
N2 - Asthma in older adults (often classified as those 65 years or older) is relatively common, underdiagnosed, and suboptimally treated. It is an important health problem, as the population of the United States continues to age. Unfortunately, asthma morbidity and mortality rates are highest in this age group. Alterations in the innate and adaptive immune responses occur with aging, and contribute to pathophysiologic differences and subsequent treatment challenges. The symptoms of asthma may differ from those in younger populations, and often include fatigue. There are unique factors that can complicate asthma management among older adults, including comorbidities, menopause, caregiver roles, and depression. Pharmacologic therapies are often not as effective as in younger populations, and may have greater side effects. Spirometry, peak flow measurements, and asthma education are typically underused, and may contribute to delays in diagnosis as well as worse outcomes. There are specific strategies that health care providers can take to improve the care of older adults with asthma.
AB - Asthma in older adults (often classified as those 65 years or older) is relatively common, underdiagnosed, and suboptimally treated. It is an important health problem, as the population of the United States continues to age. Unfortunately, asthma morbidity and mortality rates are highest in this age group. Alterations in the innate and adaptive immune responses occur with aging, and contribute to pathophysiologic differences and subsequent treatment challenges. The symptoms of asthma may differ from those in younger populations, and often include fatigue. There are unique factors that can complicate asthma management among older adults, including comorbidities, menopause, caregiver roles, and depression. Pharmacologic therapies are often not as effective as in younger populations, and may have greater side effects. Spirometry, peak flow measurements, and asthma education are typically underused, and may contribute to delays in diagnosis as well as worse outcomes. There are specific strategies that health care providers can take to improve the care of older adults with asthma.
KW - Asthma
KW - Asthma COPD overlap syndrome
KW - Depression
KW - Education
KW - Elderly
KW - Immunosenescence
KW - Menopause
KW - Older adults
KW - Spirometry
UR - http://www.scopus.com/inward/record.url?scp=85046158762&partnerID=8YFLogxK
U2 - 10.1016/j.jaip.2018.02.007
DO - 10.1016/j.jaip.2018.02.007
M3 - Article
C2 - 29747982
AN - SCOPUS:85046158762
SN - 2213-2198
VL - 6
SP - 764
EP - 773
JO - Journal of Allergy and Clinical Immunology: In Practice
JF - Journal of Allergy and Clinical Immunology: In Practice
IS - 3
ER -